Participants
- Dr Lisa Devine - National Clinical Lead for Diabetes, Irish College of GPs and HSE
- Dr John Maher - Host
Summary
This is the second part of my conversation with Lisa, so please listen to part 1 first, if you haven’t already done so.
Today, Lisa continues our discussion, with topics including:
- Pharmacological interventions, with a focus on individualising therapies;
- Managing other CV risk factors in T2DM;
- Potential Complications;
- Audit opportunities.
Links
Disclaimer
The information provided in this podcast is for educational and informational purposes only. It is not intended to serve as medical advice, diagnosis, or treatment, nor does it replace independent clinical judgment or consultation with a qualified healthcare professional.
The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of the Irish College of GPs.
Listeners are encouraged to review current clinical guidelines, product labelling, and relevant policies before applying any information discussed in this podcast.
This podcast does not establish a doctor–patient relationship. Healthcare professionals should exercise their own professional judgment in evaluating and applying information to specific clinical situations. Patients or members of the public should seek advice from their own qualified healthcare provider regarding any medical condition or treatment. It may not be possible or appropriate in all circumstances to follow the advice/processes suggested in this podcast, for example due to resource availability.
While efforts are made to ensure accuracy, medicine is a constantly evolving field, and no guarantee is made regarding the completeness, accuracy, or timeliness of the information presented.
By listening to this podcast, you acknowledge and agree that the hosts, guests, producers, affiliated organizations and the Irish College of GPs are not liable for any direct or indirect consequences resulting from the use of the information provided.